RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Collezione AOU Città della Salute di Torino

Items : 6

Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study. in European heart journal. Cardiovascular pharmacotherapy / Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):391-402. doi: 10.1093/ehjcvp/pvae024.

2024
AOU Città della Salute di Torino

Bruno F; Wenzl FA; De Filippo O; Kraler S; Giacobbe F; Roffi M; Muller O; Räber L; Templin C; De Ferrari GM; D'Ascenzo F; Lüscher TF;

External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis. in European heart journal. Cardiovascular pharmacotherapy / Eur Heart J Cardiovasc Pharmacother. 2023 Dec 14;9(8):709-721. doi: 10.1093/ehjcvp/pvad063.

2023
AOU Città della Salute di Torino

Munafò AR; Montalto C; Franzino M; Pistelli L; Di Bella G; Ferlini M; Leonardi S; D'Ascenzo F; Gragnano F; Oreglia JA; Oliva F; Ortega-Paz L; Calabrò P; Angiolillo DJ; Valgimigli M; Micari A; Costa F;

Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis. in European heart journal. Cardiovascular pharmacotherapy / Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):768-776. doi: 10.1093/ehjcvp/pvab088.

2022
AOU Città della Salute di Torino

Ameri P; De Marzo V; Zoccai GB; Tricarico L; Correale M; Brunetti ND; Canepa M; De Ferrari GM; Castagno D; Porto I;

P2Y12 inhibitors monotherapy after short course of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials including 29?089 patients. in European heart journal. Cardiovascular pharmacotherapy / Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):196-205. doi: 10.1093/ehjcvp/pvaa038.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ibáñez B; Biondi-Zoccai G; Anselmino M; D'Ascenzo F; Vizzari G; Campo G; Rossini R; Quadri G; Luciano A; Perrelli MG; Destefanis P; Careggio A; Bianco M; Montagna L; Varbella F; Cerrato E;

Off-label use of reduced dose direct oral factor Xa inhibitors in subjects with atrial fibrillation: a review of clinical evidence. in European heart journal. Cardiovascular pharmacotherapy / Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):334-345. doi: 10.1093/ehjcvp/pvaa103.

2021
AOU Città della Salute di Torino

Bo M; Corsini A; Brunetti E; Isaia G; Gibello M; Ferri N; Poli D; Marchionni N; De Ferrari GM;

P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects. in European heart journal. Cardiovascular pharmacotherapy / Eur Heart J Cardiovasc Pharmacother. 2020 Jan 1;6(1):31-42. doi: 10.1093/ehjcvp/pvz048.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

López-Cuenca A; Dominguez-Rodriguez A; Montefusco A; Conrotto F; Morbiducci U; Gallo D; Kawashiri MA; Muñoz Pousa I; Nie SP; Cespón Fernández M; González Juanatey JR; Huczek Z; Cobas Paz R; Caneiro Queija B; Alexopoulos D; Quadri G; Garay A; Blanco PF; Kawaji T; Varbella F; Magnani G; Gili S; Song X; Durante A; Fujii T; Taha S; Montabone A; Iannaccone M; Nuñez-Gil I; et alii...